PAB 0.00% 0.3¢ patrys limited

patrys is a leader in igm antibody development, page-7

  1. 16,494 Posts.
    lightbulb Created with Sketch. 777
    If we get results of course big pharma will take the drug forward. They dont care about the science because they couldn't scale up the antibody to a commercial scale.


    http://www.patrys.com/index.php/joomla/natures-weapons-against-cancer


    It is also important to note that the method by which natural human antibodies kill cancer is completely different than any products on the market - the antibodies bind to new targets on cancer cells that have yet to be discovered using other technologies. That is, these natural human antibodies offer completely new mechanisms and alternatives in the fight against cancer.

    The combination of effectiveness/potency, safety, and new mechanisms for killing cancer provides a very promising profile for the therapeutic use of natural human antibodies for cancer.

    The promise of natural human antibody based therapeutics has been well documented by third party literature - however, their advanced development has been substantially hampered by the lack of technologies that allowed for the effective large scale production and purification of natural human antibodies - particularly of the IgM isotype.

    Patrys has overcome this traditional hurdle by becoming the first in the industry with the ability to effectively manufacture and produce natural human IgM molecules at a commercial scale.
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $6.172M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
35 40042144 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 10681500 13
View Market Depth
Last trade - 16.12pm 05/11/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.